AstraZeneca’s Tozorakimab Hits Key Goals in Phase 3 COPD Trials, Signaling a Potential Blockbuster Shift in Respiratory Care.
admin In a pair of late-stage trials, a drug from AstraZeneca reduced the dangerous flare-ups that...
Health
Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation
Novo Nordisk confirmed late Friday that it had informed trial investigators of its decision to...
Internal Investigation Into American Diabetes Association Conference Expulsions Reopened Following Omissions in Initial Report.
The unfolding controversy surrounding the American Diabetes Association (ADA) and its handling of member expulsions...
FDA pilot offers generative AI medical devices a path to patients before they are authorized
The program represents a significant shift in the federal government’s philosophy toward digital health. Historically,...
Ultragenyx Faces Major Setback in Angelman Syndrome Trial as Revolution Medicines Charts New Success in Lung Cancer Research.
The biotechnology sector experienced a day of stark contrasts as two major clinical updates reshaped...
OpenEvidence launches new family of AI models
The regulatory landscape, traditionally characterized by its deliberate and cautious pace, is facing an unprecedented...
Morning Rounds: Why drug overdose deaths are decreasing and the legal battle over disability rights.
The landscape of American public health is undergoing a series of tectonic shifts, ranging from...
Anthony Fauci Warns of ‘Selective Amnesia’ as the Nation Reevaluates COVID-19 Pandemic Mitigation Strategies.
In a series of recent public reflections and high-stakes congressional testimonies, Dr. Anthony Fauci, the...
The Politics of Public Health: How the Dispute Over Measles Data Threatens National Safety.
Amid soaring measles cases across the United States, a high-stakes confrontation has emerged between the...
Safety Setbacks and Transparency Concerns Cloud the Future of CAR-T Therapies for Autoimmune Diseases.
The burgeoning field of cell therapy for autoimmune disorders, once hailed as the next frontier...
